Innovus Pharmaceuticals Inc (INNV) 0.4750

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Innovus Pharmaceuticals Inc (INNV) 0.4750 $INNV

SECFilings.com: Innovus Pharma (INNV) Reaches a Positive Cash Flow & Issues Strong Outlook
Marketwired - Thu Aug 18, 5:00AM CDT
Independent Analyst Suggests Price Target 170% Higher Than Current Levels Based on Strong Future Growth and Profitability

SeeThruEquity Issues Update on Innovus Pharmaceuticals, Inc. (OTCQB: INNV) and Raises Price Target to $1.00
ACCESSWIRE - Mon Aug 15, 5:00AM CDT
NEW YORK, NY / ACCESSWIRE / August 15, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Innovus Pharmaceuticals, Inc. (OTCQB: INNV).

SECFilings.com: Innovus Pharma (INNV) Quarterly Revenue Soars Past $1M on 446% Growth With Positive Cash Flow
Marketwired - Thu Aug 11, 5:00AM CDT
REDONDO BEACH, CA--(Marketwired - Aug 11, 2016) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the release of an article covering Innovus Pharmaceuticals' (OTCQB: INNV) recent quarterly financial results and the numerous upcoming catalysts for the company's stock.

Innovus Pharma Turns Cash Flow Positive With Over $1 Million in Revenues for the Second Quarter 2016
Marketwire Canada - Tue Aug 09, 2:47PM CDT
Company Affirms Its Previously Announced Revenue Guidance of $5 Million for 2016

Innovus Pharmaceuticals to Host Its Second Quarter 2016 Financial Report Conference Call on August 9, 2016 at 4:15 p.m. EDT
Marketwire Canada - Fri Aug 05, 1:00PM CDT
SAN DIEGO, CA--(Marketwired - Aug 5, 2016) - Innovus Pharmaceuticals, Inc. ("Innovus Pharma" www.innovuspharma.com (OTCQB: INNV) announced today it will release its second quarter 2016 financial results before the open of trading on Tuesday, August 9, 2016 ahead of its 10-Q to be filed on August 15, 2016. The company will host a conference call at 4:15 p.m. EDT/1:15 p.m. PDT on the same day (August 9, 2016) to discuss the financial results and recent business developments.

Innovus Pharma Resumes Commercial Sale of Zestra With the Appointment of PT Laras Bumi Resources as Its Distributor for Select Asian Countries Including Japan, Korea, Indonesia and China
Marketwired - Thu Aug 04, 5:00AM CDT
PT Laras Bumi Resources Projects Close to 150,000 Units a Year

Innovus Pharmaceuticals Announces the Closing of Its $3M Private Financing From Institutional Investors
Marketwired - Mon Aug 01, 5:00AM CDT
Company in a Strong Cash Position for Product Launches and Expedited Growth

SECFilings.com Examines Innovus Pharmaceuticals' (INNV) Position in Multi-Billion Dollar Female Sexual Dysfunction Market
Marketwire Canada - Tue Jun 21, 8:01AM CDT
REDONDO BEACH, CA--(Marketwired - Jun 21, 2016) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, takes a look at the underserved Female Sexual Interest Arousal Dysfunction (FSI/AD) market and Innovus Pharmaceuticals' (OTCQB: INNV) clinically proven over-the-counter treatment, Zestra®.

Innovus Pharmaceuticals Announces Successful Top Line Results From RecalMax in Memory, Processing Speed and Thought Maintenance
Marketwired - Mon Jun 13, 5:00AM CDT
SAN DIEGO, CA--(Marketwired - Jun 13, 2016) - Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCQB: INNV), a company focusing on the commercialization of over-the-counter ("OTC" and consumer products for men's and women's health, vitality and respiratory diseases, announced today that the Company's top line results from its RecalMax™ U.S. four month human survey use clinical trial in people with low memory and learning.

Innovus Pharma (INNV)'s Vesele Could Be the Best Complementary Product for Viagra and Cialis's $3.2 Billion Dollar Erectile Dysfunction Market
Marketwire Canada - Thu Jun 09, 5:00AM CDT
SAN DIEGO, CA--(Marketwired - Jun 9, 2016) -  Innovus Pharma (OTCQB: INNV) -- The global erectile dysfunction drug market is expected to reach $3.2 billion USD by 2022 according to a new report by Grand View Research Inc. Male sexual dysfunction has become a multi-billion-dollar market fueled by sales of erectile dysfunction drugs like Viagra and Cialis. In fact, Pfizer Inc.'s Viagra surpassed $1 billion in sales during its first year despite having lower than usual third-party coverage. The drug has consistently surpassed $1 billion per year in sales since its launch and even briefly reached above the $2 billion mark back in 2012 despite growing competition.
PFE: 34.98 (-0.21)

Innovus Pharma Announces the Filing of the Product Licenses for Zestra, Zestra Glide, EjectDelay and Sensum+ With the Indian FDA (Directorate General of Health Services) by Its Partner Khandelwal Laboratories
Marketwire Canada - Tue Jun 07, 5:00AM CDT
SAN DIEGO, CA--(Marketwired - Jun 7, 2016) - Innovus Pharmaceuticals, Inc. ("Innovus Pharma" (OTCQB: INNV), an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men and women's health and respiratory diseases, today announced today that its partner Khandelwal Laboratories filed the product licenses for Zestra®, Zestra Glide®, EjectDelay® and Sensum+® with the Indian FDA, The Drugs Controller General (India) and the Directorate General of Health Services to commercialize the products in India.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 75

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
Africa Tech Awards Put Infrastructure Back in Focus

Updated Category News Views 97

Twelve trophies in Cape Town tell a more useful story than most glossy technology forecasts ever manage to. The Africa Tech Festival Awards 2026, announced on November 19 during the event's 29th annual gathering, cut across connectivity, telecoms, AI, cybersecurity, data centres, cloud, fintech, startups and enterprise transformation. That breadth matters. Africa's...

Continue Reading
NEWWAVE Turns 15 and Chases a Bigger Tech Partner Role

Updated Category News Views 48

Fifteen years is about when an outsourced engineering shop has to prove it can be more than extra hands on a keyboard. NEWWAVE’s new identity and “Trusted Technology Partner” positioning are an attempt to make that jump: from carrying out software work to helping clients decide what work ought to be done, then sticking around after launch. It is a sensible ambition,...

Continue Reading
Securitize Tests the IPO Clock With Anthropic Tokens

Updated Category News Views 93

Anthropic did not even get a full trading day to itself before the tokenization crowd arrived. Securitize says Anthropic stock became available through Securitize Stocks on Solana on the company’s first day as a public company, a loud little signal that the old IPO playbook is being prodded from the edges. For investors, this is not merely another crypto-flavored...

Continue Reading
Cirrus CEO Takes SIA Chair as Chip Policy Heats Up

Updated Category News Views 148

A trade-group gavel rarely moves a stock by itself, but this one lands in a noisy part of the chip cycle. On November 19, 2026, the Semiconductor Industry Association elected Cirrus Logic President and CEO John Forsyth as chair of its board. That is not a revenue announcement, not a factory groundbreaking, and certainly not a reason to start flinging confetti at...

Continue Reading
Huhtamaki Maps Its 2027 Reporting Dates for Investors

Updated Category News Views 78

A calendar release rarely makes the pulse race, but it tells shareholders when the curtain will actually go up. Huhtamäki Oyj has laid out its 2027 financial reporting timetable, and the useful part is its plainness: investors now know the handful of dates when management will have to put numbers, not broad ambitions, in front of the market. For a packaging company, that...

Continue Reading
Korla Kiln Gains Show How Cement Efficiency Is Won

Updated Category News Views 53

A cement kiln does not care about corporate slogans; it cares whether the flame holds, the bearings stay alive, and the feed keeps moving. That is why the work at Xinjiang Tianshan Cement's Tashidian branch in Korla deserves a closer look. This is not a glossy tale about a futuristic factory appearing overnight. It is an account of an old, unforgiving industrial process...

Continue Reading
FLX Opens a New Door to Pre-IPO Deal Flow for Advisors

Updated Category News Views 172

Private-market chatter has been leaking past the velvet rope for years, and advisors are sick of learning about it after a client already has a pitch deck in hand. FLX Networks is responding to that irritation by letting its eligible advisor and wealth-management members review select pre-IPO opportunities shared by other members. Announced November 19, 2026, the move is...

Continue Reading
Humana's Medicare Audit Shock Puts Disclosure in Focus

Updated Category News Views 134

Medicare Advantage just reminded Wall Street that reimbursement plumbing can wreck a perfectly calm-looking stock in a hurry. Humana shareholders watched that lesson land hard on November 18, when reports surfaced of a proposed federal CRUSH rule aimed at fraud, waste, and improper payments in the program. The reported response in NYSE:HUM was ugly: an early account put...

Continue Reading
Sailun’s COP31 Pitch Rests on Tire Tech and Hard Proof

Updated Category News Views 91

Antalya Put Tire Chemistry on a Very Public Stage Rubber tires rarely get a starring role at a climate summit, which is exactly why Sailun Group’s appearance at COP31 deserves a closer look. From November 9 through 20 in Antalya, Türkiye, Chairwoman Yanhua Liu used the United Nations climate gathering to lay out the company’s case: better tire technology can cut...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Trends: The Effects of Inflation on Stock Futures

Updated Category News Views 87

Understanding Stock Market Movements Amid Inflation The stock market is always changing, and the way inflation data interacts with labor statistics often shapes its future direction. Recently, U.S. stock futures saw a slight uptick as investors digested fresh figures, weighing how these will influence upcoming decisions regarding interest rate cuts. Current Market...

Continue Reading
SMBC Nikko America Achieves Primary Dealer Status with Fed

Updated Category News Views 557

SMBC Nikko America Achieves Primary Dealer Designation SMBC Nikko Securities America, Inc., commonly referred to as SMBC Nikko America, has recently been honored with the designation of primary dealer by the Federal Reserve Bank of New York. This prestigious status is not only a recognition of the firm’s robust capabilities but also signals significant opportunities for...

Continue Reading
USD and Global Currency Trends Amid Upcoming Economic Events

Updated Category News Views 272

Currency Market Insights for the Upcoming Week As economic indicators and central bank policies loom large, the focus shifts to the financial markets where currencies react to evolving data. The US dollar has shown resilience recently, making a notable comeback. This rebound is attributed to a combination of safe haven flows and exceptionally positive data releases. Fed...

Continue Reading
Transforming $100 into Wealth: American Tower's Success Story

Updated Category News Views 152

The Wealth Generated by American Tower's Growth American Tower (NYSE: AMT) has exhibited exceptional performance over the past two decades, consistently outshining the market with a remarkable annual return of 10.05%. As of now, this powerhouse company boasts a market capitalization of approximately $83 billion, signaling its robust position in the telecommunications...

Continue Reading
Calcea: The Future of Calcium with Plant-Based Solutions

Updated Category News Views 258

Revolutionizing Calcium Supplements with Calcea Calcium is recognized as the most abundant mineral in the human body, yet many of the supplements available today are derived from ground-up rocks – materials that aren't aligned with the nutritional needs of the human body. With consumers increasingly prioritizing cleaner and more effective supplements, the calcium market...

Continue Reading